Related Image: Survey Shows Parents' Best Intentions Out of Step With Expert Recommendations in Protecting Kids From Flu |
(Date:12/1/2008)..., findings may help improve treatment for psychiat...Day News) -- Children with lower IQ have an increa...generalized anxiety disorder and other psychiatric... than three decades shows. , Lower childhood IQ...on and anxiety, as well as an increased risk of ha...
(Date:12/1/2008)...re/ -- Amanzi Tea ( www.amanzitea.com ), a unique ...bration of its first Manhattan location opening Sa...tea flu shots" made of double strength, freshly br...d 20th from noon until four. This is a healthy an...e onset of winter. , , In a recent study,...
(Date:12/1/2008)...RNewswire-USNewswire/ -- As part of the Dec. 1 o...ealth Everette James today urged Pennsylvanians to...e also highlighted ongoing efforts to educate the ..., , "Our message is clear: regardless of yo...ing tested for HIV is the only sure way to know yo...
(Date:12/1/2008)...ly assess coronary artery stenosis, according to a...l Center in Leiden, The Netherlands. , The stud...ronary artery disease with 50% or more stenosis. 1...g the study. "We found a 98% sensitivity rate for ...our patients; specificity was 91%," said Lucia J.M...
Breaking Medicine News(10 mins):Health News:Low Childhood IQ Tied to Risk of Later Mental Disorders 2Health News:Amanzi Tea offers free, natural 'Flu Shots' to New Yorkers 2Health News:PA Department of Health Recognizes 20th Anniversary of World AIDS Day; Urges HIV Testing 2...east six-times more likely to kill high-risk women...// say researchers based on findings of a recent s...or who were at high risk because of diabetes or mu...men were assessed for three years to determine how...
...a recent study researchers say girls are affected ...s may explain this difference between girls and bo...rs are in the process of conducting a study which ...ulin-resistant and why. The study included 307 hea...
...g radiation therapy to a treatment regimen already... // leads to better survival outcomes among women...ide effects. Ina study done between 1979 and 1986... receive radiation therapy or no radiation at all....
...heart disease risk factors may reduce the risk of ...ecent study // which shows that cardiovascular ris... the risk of dementia in old age. Risk factors fo...olesterol, hypertension, diabetes and smoking. Eac...
Other Medicine News:(Date:11/24/2008)...RNewswire-FirstCall/ -- Leaders of Schering-Plough...te for investors on the company,s research pipelin...at includes 46 new entities in clinical trials or ...ies. , , "Research and development is addin...ntinue our transformation," said Fred Hassan, chai...
(Date:11/24/2008)...ay Unveils Rich Development Pipeline of Compounds ...RTH, N.J., Nov. 24 Scher...ed top-line results of a long-term Phase III clini...(TM) (asenapine) demonstrating efficacy and safety...trial, asenapine was statistically significantly m...
(Date:11/24/2008)... GeneThera, Inc.,(Pink S...ring its Real Time,PCR test for Johne,s disease t... GeneThera is set to begin offering its Johne,s di... According to GeneThera Chairman, Dr. Tony Milici...me PCR test for Johne,s disease,called HerdGuard...
(Date:11/24/2008)..., November 24 NicOx,S.A...the third pivotal phase,3 study for naproxcinod i...tistically significant result (p<0.001) on all ... Naproxcinod 750 mg bid showed the same,gastroint...d pressure profile,to placebo. Naproxcinod is the...
Breaking Medicine Technology:Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 2Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 5Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention 2Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention 3GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 2GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 3GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 4Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results 2Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results 3Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results 4Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results 5AGU journal highlights Sept 3 2008 4700 1AGU journal highlights Sept 3 2008 4700 2AGU journal highlights Sept 3 2008 4700 3AGU journal highlights Sept 3 2008 4700 4AGU journal highlights Sept 3 2008 4700 5AGU journal highlights Sept 3 2008 4700 6AGU journal highlights Sept 3 2008 4700 7Demystifying Medicare and Long Term Care Insurance Healthcare Liaison Workshop 9 20 Shows Consumers How to Make Choices 26030 1Demystifying Medicare and Long Term Care Insurance Healthcare Liaison Workshop 9 20 Shows Consumers How to Make Choices 26030 2Inverness Medical Innovations to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9 2008 7458 1Monitoring immune responses in disease 26024 1...ERKELEY HEIGHTS, NJ – June 4, 2007 – G...sentation of results,from a Phase 2 clinical trial...rate injection), plus rituximab (Rituxan®;,Gen...lapsed or,refractory non-Hodgkin’s lymphoma ...ng of the American Society of Clinical,Oncology (A...
...HICAGO--(BUSINESS WIRE)--Jun 4, 2007 - Introgen Th...clinical collaborators today,reported updated Phas...etween abnormal p53, tumor responses and increased... with recurrent,squamous cell carcinoma of the hea...ed today at the annual meeting of the American,Soc...
Other Medicine Technology:Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 2Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 4Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 5Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 2Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 3Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 4...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
Medicine Products: